Clinical Trials Directory

Trials / Unknown

UnknownNCT04150302

Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives

Development and Validation of a Questionnaire to Measure the Impact of Short Bowel Syndrome (SBS) and Its Treatments on Patients' Lives

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Today, patients express a very strong need to take into account the consequences of their disease and its treatments in their therapeutic follow-up. It is therefore essential to better understand the needs, expectations and values of patients with SBS in order to better understand the impact of the disease on their lives, and thus improve the conditions for medical, social, psychological and technical care. The clinical expertise of health professionals and meetings with patient associations demonstrate the major gap between the parameters taken into account by physician to evaluate the evolution of the SBS and the day-to-day experience of the disease perceived by the patient. The objective of the ARTEMIS-GC study is to develop and validate an instrument to measure the impact of SBS and its treatments on daily life from the perspective of patients.

Conditions

Interventions

TypeNameDescription
OTHERExploratory interviewsExploratory interviews to generate an interview guide
OTHERSemi-directive interviewsSemi-directive interviews to collect qualitative data that will be used for questionnaire item generation
OTHERDelphi ProcessCotation of newly developed items pertinence on a 4 points likert scale.
OTHERThink aloud interviewsDebriefing session for the newly developed items: final possibility to adjust the tool before validating the psychometric proprieties of the questionnaire.
OTHERPsychometric validationPsychometric properties study

Timeline

Start date
2020-01-01
Primary completion
2020-01-01
Completion
2021-06-01
First posted
2019-11-04
Last updated
2019-11-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04150302. Inclusion in this directory is not an endorsement.